Maravai LifeSciences

Maravai LifeSciences is a biotechnology company headquartered in San Diego, California. The privately held company employs over 100 people and generates an annual revenue of $500 million. Maravai LifeSciences specializes in providing nucleic acid products, enzyme development, and biologics safety testing solutions to the life sciences industry. Their portfolio includes revolutionary mRNA technologies used in the development of infectious disease vaccines, cancer vaccines, and cell and gene therapies. They also offer gold-standard bioprocess impurity detection solutions that assist companies in streamlining and scaling their operations from research through commercialization. Maravai LifeSciences prides itself on its extensive experience, holding numerous patents and offering over 1,500 innovative products and services. These include CleanCap® technology, CleanAmp® hot start PCR, Antibody Affinity Extraction™, EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV®, Sterling™, Glen Pak™, and Glen Gel-Pak™. Each of their brands is ISO-9001:2015 certified and has earned widespread recognition in the scientific community, with hundreds of thousands of citations in peer-reviewed publications. For more information about Maravai LifeSciences and their products and services, please visit their website at maravai.com.